Rethinking hEDS
Dec. 29, 2025
MUSC Progressnotes Medical Magazine
Stay informed of the latest clinical and scientific innovations through engaging and scientifically sophisticated articles in MUSC Progressnotes.
Latest in Progressnotes
Displaying 1 - 15 of 129 Results
Increased remission rate for depression with new method of TMS, now offered at MUSC
Aug. 9, 2024
New FDA-approved drug for pulmonary hypertension targets disease, not just symptoms
Aug. 9, 2024
Special clinics at MUSC help adolescents with chronic illnesses shift from pediatric to adult care
Aug. 9, 2024
Interdisciplinary team at MUSC Hollings Cancer Center maps role of P. gingivalis in drug resistance
Aug. 9, 2024
First U.S. trial of varenicline for e-cigarette cessation shows positive results
Aug. 9, 2024
Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma
Aug. 9, 2024
Investigating critcal factor for promoting drug-context associations and relapse
Aug. 9, 2024
Targeting "monster cancer cells" could reduce recurrence rates after cancer therapy
Aug. 9, 2024
Surgical suction-clearing device developed at MUSC now ready to launch nationally
Aug. 9, 2024
Bench to Bedside: MUSC physician-scientist battles viruses in lab and clinic
Aug. 9, 2024
Pulse field ablation offers new option for atrial fibrillation patients with fewer risks
Aug. 9, 2024
A conversation with MUSC Health CHS Division CEO Saj Joy
Aug. 9, 2024
MUSC Health finds 20% reduction on documentation following adoption of AI-driven technology
Aug. 9, 2024
Hooked on a feeling: Opioids evoke positive feelings through a newly identified brain region
Aug. 9, 2024
